Search
Monopar Therapeutics Inc
MNPRAdd to Watchlist
110.450USD
+0.580+0.53%
Close 07-27 16:00（ET）Quotes delayed by 15 min
739.91MMarket Cap
LossP/E TTM
Monopar Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-27The current valuation score of Monopar Therapeutics Inc is 9.36, ranking 37 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -57.13, which is -96.44% below the recent high of -2.03 and -5.16% above the recent low of -60.08.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.